Skip to content

SCIEMPATH BIO

Active Private limited companyfounded 2014active for 12 yearsGrand'Route 99, 1428 Braine-l'AlleudKBO/BCE: BE 0561.779.953

Annual accounts 2024

micro format, filed on 28-08-2025, 28 days late

2025 annual accounts not yet filed, deadline passed on 31 July 2026 The financial year closed on 31 December 2025. The accounts are due at the latest 7 months after the close (Companies Code art. 3:10). Source: NBB filings, as of 11 November 2026.

€49,134
▲ 10.7%
€38,724
▲ 3.2%
€93,217
▼ 8.7%
€224,386
▲ 13.1%
47.1%
▲ 2.1 percentage points
1.70
▲ 0.03

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €200,000. Estimated: probably between €120,000 and €360,000.

Balance sheet

balance sheet total €608,601 on 31-12-2024
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

47.1%

Higher than 37% of 626 companies in 2024.

1.70

Higher than 34% of 607 companies in 2024.

15.3%

Higher than 60% of 613 companies in 2024.

SCIEMPATH BIO Middle half of the sector 80% of the sector Micro accounts in research and development (NACE 72)

Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2024202320222021202020192018201720162015
Balance sheet: assets
20/58 608,601541,478462,521377,640161,431133,851136,275150,359110,26987,230
21/28 62,03846,33051,64944,34143,88745,39665,16381,49267,80036,970
21 ------1,6004,0007,31111,076
22/27 23,5417,83313,1525,8445,3906,89925,06647,27030,26725,893
23 --------2,3265,813
24 23,5396,79910,7701,958-416,66837,36816,53516,472
26 21,0352,3823,8865,3906,8948,3989,90211,4063,608
28 38,49738,49738,49738,49738,49738,49738,49730,22230,222-
29/58 546,563495,148410,872333,300117,54488,45571,11268,86742,46850,260
40/41 106,479242,242150,151220,15992668,52525,0455,06111,5201,844
40 104,964241,785148,487218,498-66,48123,9593,0768,691-
41 1,5164571,6641,6629262,0441,0861,9852,8291,844
54/58 440,084252,906259,412110,839114,37517,72643,78361,55028,03347,255
490/1 --1,3092,3012,2442,2042,2852,2562,9161,161
Balance sheet: equity and liabilities
10/49 608,601541,478462,521377,640161,431133,851136,275150,359110,26987,230
10/15 286,424243,206241,090293,997145,942106,770112,469110,38288,67755,091
10/11 30,00030,00030,00030,00030,00030,00030,00030,00030,00030,000
100 -----30,00030,00030,00030,00030,000
13 24,50024,50024,50024,50024,50024,50024,50024,50023,75012,550
130/1 3,0003,0003,0003,0003,000-----
130 -----3,0003,0003,0002,2501,050
1311 3,0003,0003,0003,0003,000-----
132 21,50021,50021,50021,50021,50021,50021,50021,50021,50011,500
14 231,924188,706186,590239,49791,44252,27057,96955,88234,92712,541
17/49 322,177298,272221,43183,64415,48927,08123,80639,97721,59132,139
17 ------7,19914,197--
170/4 ------7,19914,197--
42/48 322,177296,787221,43183,51715,48926,98316,51124,44721,59132,043
42 -----7,1996,9986,803--
44 1331,783-58866954588867,627403
440/4 1331,783-58866954588867,627403
46 ---------2,481
45 38,29446,25446,43132,82915,4234,6893,05011,71411,9506,111
450/3 21,19125,09146,43132,82915,4234,6893,05011,71411,9506,111
454/9 17,10321,163--------
47/48 283,750248,750175,00050,100-15,0006,0065,0442,01523,048
492/3 -1,485-127-98961,334-96
Income statement
76A ------98---
9900 49,13444,39761,343129,87354,16935,11730,81661,70663,73855,504
630 2,7755,3192,5431,6121,50819,76724,60429,28617,30017,863
640/8 7,6351,5541,0661,0398381,0129171,81212985
9901 38,72437,52457,734127,22351,82314,3385,29530,60846,30937,555
75/76B 62,93874,00978,198101,2390110-475
75 62,93874,00978,198101,2390110-475
65/66B 1,1575335747761,0101,4601,6595573,6841,179
65 1,1575335747761,0101,4601,6595573,6841,179
9903 100,506111,001135,358227,68650,81212,8793,63630,05142,62636,852
67/77 7,2888,88513,26429,63111,6403,5781,5498,3469,0394,761
9904 93,217102,116122,093198,05539,1729,3012,08721,70533,58632,091
689 --------10,00011,500
9905 93,217102,116122,093198,05539,1729,3012,08721,70523,58620,591
Appropriation of the result
9906 281,924288,706361,590289,49791,44267,27057,96956,63236,12720,591
14P 188,706186,590239,49791,442------
691/2 -------7501,2001,050
6920 -------7501,2001,050
694/7 50,000100,000175,00050,000-15,000---7,000
694 50,000100,000175,00050,000-15,000----
695 ---------7,000
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 10 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2024 (PDF), filed on 28-08-2025.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2024 micro format 28-08-2025 2025-00479201 PDF
31-12-2023 micro format 26-08-2024 2024-00429495 PDF
31-12-2022 micro format 02-10-2023 2023-00472209 PDF
31-12-2021 micro format 31-08-2022 2022-20422494 PDF
31-12-2020 micro format 13-09-2021 2021-67500502 PDF
31-12-2019 micro format 12-08-2020 2020-41800032 PDF
31-12-2018 micro format 30-08-2019 2019-63300191 PDF
31-12-2017 micro format 24-09-2018 2018-65600396 PDF
31-12-2016 micro format 21-09-2017 2017-62300337 PDF
31-12-2015 full format 10-06-2016 2016-17900227 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2024202320222021202020192018201720162015
41,49942,84360,277128,83453,33134,10529,89959,89463,60955,419
95,992107,435124,637199,66640,68129,06826,69150,99150,88649,954
24,70009,8522,065008,27542,97848,13054,833
187,178-6,505148,572-3,53696,648-26,056-17,76833,517-19,223-
224,386198,361189,441249,783102,05561,47254,60144,42020,87718,217
47.1%44.9%52.1%77.9%90.4%79.8%82.5%73.4%80.4%63.2%
1.701.671.863.997.593.284.312.821.971.57
1.121.230.920.280.110.250.210.360.240.58
32.5%42.0%50.6%67.4%26.8%8.7%1.9%19.7%37.9%58.3%
15.3%18.9%26.4%52.4%24.3%6.9%1.5%14.4%30.5%36.8%
35.8780.44over 100over 100------

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item2024202320222021
Tangible fixed assets€24,700-€9,852€2,065
€2,775€5,319€2,543€1,612

Source: notes to the 2021 to 2024 annual accounts (statement of fixed assets)

Insights on SCIEMPATH BIO

The operating result for 2024 is 3% higher than in 2023. It is a recovery after the fall in 2023.

Debt's share of the balance-sheet total falls from 55.1% to 52.9%. Equity and debt are higher.

Next steps